Insider · CIK 0001862617
Ramtin Agah
Files at RNXT (RenovoRx, Inc.). First filing Apr 9, 2025, latest Jan 22, 2026.
Ramtin Agah files SEC Form 4 as officer and director at RNXT (RenovoRx, Inc.). Since Apr 9, 2025, Ramtin Agah has reported 11 open-market buys worth $161k and 0 open-market sells worth $0, the latest filed on Jan 22, 2026.
A track record needs three past buys with six months of prices behind them; Ramtin Agah has 0, so none is measured yet.
The newest scored trade: bought $9,975 of RNXT on Jan 21, 2026, filed Jan 22, 2026, scored 28 (weak). In the last 12 months: 6 buys worth $56k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RNXT: RenovoRx, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | RNXTbuy RenovoRx, Inc. | $9,975 10,000 shares | +1% | +36% from low-35% from high | |
| 36Weak | RenovoRx, Inc. | $8,424 9,795 shares | +1% | +15% from low-45% from high | |
| 31Weak | RenovoRx, Inc. | $169 205 shares | +0% | +19% from low-43% from high | |
| 36Weak | RenovoRx, Inc. | $10k 12,000 shares | +2% | +15% from low-45% from high | |
| 36Weak | RenovoRx, Inc. | $9,600 10,000 shares | +1% | +28% from low-39% from high | |
| 33Weak | RNXTbuy RenovoRx, Inc. | $18k 22,000 shares | +3% | +9% from low-48% from high | |
| 25Weak | RNXTbuy RenovoRx, Inc. | $29k 21,000 shares | +3% | - | |
| 43Moderate | RenovoRx, Inc. | $14k 15,000 shares | +1% | +17% from low-42% from high | |
| 53Moderate | RenovoRx, Inc. | $16k 20,000 shares | +2% | 0% from low-50% from high | |
| 53Moderate | RenovoRx, Inc. | $24k 30,000 shares | +3% | +5% from low-46% from high | |
| 48Moderate | RenovoRx, Inc. | $22k 26,000 shares | +3% | +1% from low-48% from high |
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 3, 2026 | RNXT RenovoRx, Inc. | AGrant or award Stock Optionderivative | +621,727 | $0.00 | $0 | 621,727 | Apr 7, 2026 |
| Jan 21, 2026 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +10,000 | $1.00 | $9,975 | 798,460 | Jan 22, 2026 |
| Dec 31, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +9,795 | $0.86 | $8,424 | 788,460 | Jan 5, 2026 |
| Dec 30, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +205 | $0.83 | $169 | 778,665 | Jan 2, 2026 |
| Dec 16, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +12,000 | $0.85 | $10k | 778,460 | Dec 17, 2025 |
| Dec 5, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +10,000 | $0.96 | $9,600 | 766,460 | Dec 8, 2025 |
| Nov 21, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +10,000 | $0.80 | $8,000 | 744,460 | Nov 24, 2025 |
| Nov 24, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +12,000 | $0.80 | $9,600 | 756,460 | Nov 24, 2025 |
| Jul 1, 2025 | RNXT RenovoRx, Inc. | AGrant or award Stock Optionderivative | +63,636 | $0.00 | $0 | 63,636 | Jul 3, 2025 |
| Jun 5, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +21,000 | $1.40 | $29k | 734,460 | Jun 9, 2025 |
| Apr 22, 2025 | RNXT RenovoRx, Inc. | GGift Common Stock | -400,000 | $0.00 | $0 | 713,460 | Jun 6, 2025 |
| Apr 15, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +15,000 | $0.90 | $14k | 1,113,460 | Apr 17, 2025 |
| Apr 14, 2025 | RNXT RenovoRx, Inc. | AGrant or award Stock Optionderivative | +254,542 | $0.00 | $0 | 254,542 | Apr 16, 2025 |
| Apr 11, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +20,000 | $0.80 | $16k | 1,098,460 | Apr 14, 2025 |
| Apr 9, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +30,000 | $0.81 | $24k | 1,078,460 | Apr 10, 2025 |
| Apr 8, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +26,000 | $0.84 | $22k | 1,048,460 | Apr 9, 2025 |
Questions about Ramtin Agah
Answered from the filings on this page, as of the latest one.
Is Ramtin Agah buying or selling?
In the last 12 months Ramtin Agah reported 6 open-market buys worth $56k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $9,975 of RNXT on Jan 21, 2026. Grants, option exercises and tax withholding are not counted.
How did Ramtin Agah's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ramtin Agah has 0.
Where does Ramtin Agah file Form 4?
Ramtin Agah has filed Form 4 at RNXT (RenovoRx, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.